Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

International Journal of Breast Cancer
Volume 2011, Article ID 381080, 10 pages
http://dx.doi.org/10.4061/2011/381080
Research Article

Role of CEACAM1, ECM, and Mesenchymal Stem Cells in an Orthotopic Model of Human Breast Cancer

1Irell & Manella City of Hope Graduate School of Biological Sciences, Duarte, CA 91010, USA
2Department of Immunology, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA
3Department of Neurosciences, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA

Received 19 May 2010; Accepted 6 September 2010

Academic Editor: Zsuzsanna Kahaán

Copyright © 2011 Sridhar Samineni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. R. Cunha, P. Young, S. Hamamoto, R. Guzman, and S. Nandi, “Developmental response of adult mammary epithelial cells to various fetal and neonatal mesenchymes,” Epithelial Cell Biology, vol. 1, no. 3, pp. 105–118, 1992. View at Google Scholar · View at Scopus
  2. H. Parmar, P. Young, J. T. Emerman, R. M. Neve, S. Dairkee, and G. R. Cunha, “A novel method for growing human breast epithelium in vivo using mouse and human mammary fibroblasts,” Endocrinology, vol. 143, no. 12, pp. 4886–4896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Y. Lee, P. A. Kenny, E. H. Lee, and M. J. Bissell, “Three-dimensional culture models of normal and malignant breast epithelial cells,” Nature Methods, vol. 4, no. 4, pp. 359–365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. V. M. Weaver, A. H. Fischer, O. W. Peterson, and M. J. Bissell, “The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay,” Biochemistry and Cell Biology, vol. 74, no. 6, pp. 833–851, 1996. View at Google Scholar · View at Scopus
  5. T. Hasebe, N. Okada, N. Tamura et al., “P53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast,” Cancer Science, vol. 100, no. 11, pp. 2101–2108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Kuperwasser, T. Chavarria, M. Wu et al., “Reconstruction of functionally normal and malignant human breast tissues in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 4966–4971, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Kirshner, C.-J. Chen, P. Liu, J. Huang, and J. E. Shively, “CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 521–526, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Yokoyama, C.-J. Chen, T. Nguyen, and J. E. Shively, “Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation,” Oncogene, vol. 26, no. 55, pp. 7637–7646, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Gaur, J. E. Shively, Y. Yen, and R. K. Gaur, “Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms,” Molecular Cancer, vol. 7, article 46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Li, C.-J. Chen, and J. E. Shively, “Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: stimulation by Thr-457 and inhibition by Ser-461,” Experimental Cell Research, vol. 315, no. 7, pp. 1225–1233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Karnoub, A. B. Dash, A. P. Vo et al., “Mesenchymal stem cells within tumour stroma promote breast cancer metastasis,” Nature, vol. 449, no. 7162, pp. 557–563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-J. Chen, J. Kirshner, M. A. Sherman, W. Hu, T. Nguyen, and J. E. Shively, “Mutation analysis of the short cytoplasmic domain of the cell-cell adhesion molecule CEACAM1 identifies residues that orchestrate actin binding and lumen formation,” The Journal of Biological Chemistry, vol. 282, no. 8, pp. 5749–5760, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Francia, S. Man, C.-J. Lee et al., “Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts,” Clinical Cancer Research, vol. 15, no. 20, pp. 6358–6366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. D. Volk, M. J. Flister, C. M. Bivens et al., “Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrrent anti-vascular endothelial growth factor A theraphy,” Neoplasia, vol. 10, no. 6, pp. 613–623, 2008. View at Publisher · View at Google Scholar
  15. Z. Kahán, J. L. Varga, A. V. Schally et al., “Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice,” Breast Cancer Research and Treatment, vol. 60, no. 1, pp. 71–79, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Moreau, K. Anderson, J. R. Mauney, T. Nguyen, D. L. Kaplan, and M. Rosenblatt, “Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model,” Cancer Research, vol. 67, no. 21, pp. 10304–10308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Langlois, W. D. Holder Jr., and J. D. Iglehart, “Morphological and biochemical properties of a new human breast cancer cell line,” Cancer Research, vol. 39, no. 7 I, pp. 2604–2613, 1979. View at Google Scholar
  18. M. M. Richert, K. L. Schwertfeger, J. W. Ryder, and S. M. Anderson, “An atlas of mouse mammary gland development,” Journal of Mammary Gland Biology and Neoplasia, vol. 5, no. 2, pp. 227–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Fichtner, M. Becker, R. Zeisig, and A. Sommer, “In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance,” European Journal of Cancer, vol. 40, no. 6, pp. 845–851, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. D. Dubois, M. J. O'Hare, P. Monaghan, J. Bartek, R. Norris, and B. A. Gusterson, “Human breast epithelial xenografts: an immunocytochemical and ultrastructural study of differentiation and lactogenic response,” Differentiation, vol. 35, no. 1, pp. 72–82, 1987. View at Google Scholar · View at Scopus
  21. J. Hoffmann, R. Bohlamann, N. Heinrich et al., “Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer,” Journal of the National Cancer Institute, vol. 96, no. 3, pp. 210–218, 2004. View at Google Scholar · View at Scopus